E-LIB Suche - Ergebnisse für: Prelaj, A.

1

Efficacy and safety of ramucirumab plus carboplatin and pac..:

Proto, C. ; Ganzinelli, M. ; Manglaviti, S....
Annals of Oncology. 35 (2024) 9 - p. 817-826 , 2024

Link: https://doi.org/10.1016/..

2

1320P Digital pathology predicts PD-L1 expression in metast..:

Prelaj, A. ; Sacco, M. ; Miskovic, V....
Annals of Oncology. 35 (2024) - p. S840-S841 , 2024

Link: https://doi.org/10.1016/..

3

165P Tissue genomic profiling of pleural mesothelioma patie..:

Ambrosini, P. ; Brambilla, M. ; Marchesi, S....
ESMO Open. 9 (2024) - p. 102741 , 2024

Link: https://doi.org/10.1016/..

4

1906P ESMO-ESTRO consensus recommendations regarding the sa..:

van Aken, E. ; Martins Branco, D. ; De Ruysscher, D....
Annals of Oncology. 35 (2024) - p. S1110-S1111 , 2024

Link: https://doi.org/10.1016/..

5

67P Artificial Intelligence to predict early progressors am..:

Provenzano, L. ; Giuliano, M. ; Rizzo, G....
ESMO Open. 9 (2024) - p. 103073 , 2024

Link: https://doi.org/10.1016/..

6

ESMO Guidance for Reporting Oncology real-World evidence (G..:

Castelo-Branco, L. ; Pellat, A. ; Martins-Branco, D....
ESMO Real World Data and Digital Oncology. 1 (2023) - p. 100003 , 2023

Link: https://doi.org/10.1016/..

7

MA13.09 Efficacy and Safety of Poziotinib in HER2 Exon 20 I..:

Le, X. ; Prelaj, A. ; Baik, C....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S147-S148 , 2023

Link: https://doi.org/10.1016/..

8

PP01.01 PEOPLE (NTC03447678), a Phase II Trial to Test Biom..:

Dolezal, J. ; Lo Russo, G. ; Proto, C....
Journal of Thoracic Oncology. 18 (2023) 3 - p. e10 , 2023

Link: https://doi.org/10.1016/..

9

Challenges and knowledge gaps with immune checkpoint inhibi..:

Castelo-Branco, L. ; Morgan, G. ; Prelaj, A....
ESMO Open. 8 (2023) 1 - p. 100764 , 2023

Link: https://doi.org/10.1016/..

10

68P OncoMutational ratio on ctDNA: A potential novel biomar..:

Ambrosini, P. ; Provenzano, L. ; Bottiglieri, A....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S79-S80 , 2023

Link: https://doi.org/10.1016/..

11

EP08.01-006 Using Real World data to build effective predic..:

prelaj, A. ; Galli, E.G. ; Pesenti, M....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S337-S338 , 2022

Link: https://doi.org/10.1016/..

12

PEOPLE (NCT03447678), a first-line phase II pembrolizumab t..:

Lo Russo, G. ; Sgambelluri, F. ; Prelaj, A....
ESMO Open. 7 (2022) 6 - p. 100645 , 2022

Link: https://doi.org/10.1016/..

13

EP07.01-021 Clinical and Biochemical Profiling of Pleural M..:

Occhipinti, M. ; Tacchetto, A. ; Beninato, T....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S322-S323 , 2022

Link: https://doi.org/10.1016/..

14

25P Platinum-based chemotherapy (PCT) addition to first-lin..:

Ferrara, R. ; Lo Russo, G. ; Ciniselli, C.M....
Immuno-Oncology and Technology. 16 (2022) - p. 100130 , 2022

Link: https://doi.org/10.1016/..

15

EP08.02-060 How Do Oncologists Treat Patients With EGFR Exo..:

Mountzios, G. ; Planchard, D. ; Metro, G....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S427-S428 , 2022

Link: https://doi.org/10.1016/..